CSIMarket
 


Stemline Therapeutics Inc  (STML)
Other Ticker:  
 

Cumulative Stemline Therapeutics Inc's Leverage Ratio for Trailing Twelve Months Period

STML's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth



STML Leverage Ratio for Trailing Twelve Months Period

(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
(Mar 31 2019)
I. Quarter
Y / Y Equity Growth 35.59 % 287.7 % 176.11 % 23.89 % 23.72 %
Y / Y Total Liabilities Growth -15.8 % 9.73 % 30.45 % 49.06 % 38.74 %
Leverage Ratio for Trailing Twelve Months Period 0.16 0.18 0.23 0.3 0.28
Total Ranking # 265 # 351 # 443 # 597 #
Seq. Equity Growth -9.76 % -6.74 % 74.06 % -7.44 % 158.03 %
Seq. Total Liabilities Growth -1.7 % 2.77 % -16.91 % 0.31 % 28.09 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to debt repayement of -1.7% Stemline Therapeutics Inc decreased Leverage Ratio for Trailing Twelve Months Period in the I. Quarter to 0.16, below company's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Major Pharmaceutical Preparations industry 57 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Stemline Therapeutics Inc. While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 265, from total ranking in previous quarter at 351.

What is Leverage Ratio?
Who are STML's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 58
Sector # 112
S&P 500 # 264


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.33 0.18 0.06
(Dec 31 2018)   (Sep. 30, 2015)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Mar 31 2020, within Major Pharmaceutical Preparations Industry Leverage Ratio for Trailing Twelve Months Period
Sinovac Biotech Ltd  0.45 
Beigene Ltd   0.44 
Mustang Bio Inc   0.44 
Opko Health Inc   0.43 
Five Prime Therapeutics Inc   0.43 
Blueprint Medicines Corporation  0.43 
Kadmon Holdings Inc   0.43 
Zafgen Inc   0.42 
Heat Biologics Inc   0.42 
Reliv International Inc  0.42 
Oramed Pharmaceuticals Inc   0.41 
Beyondspring Inc   0.40 
Menlo Therapeutics Inc   0.39 
Aduro Biotech Inc   0.39 
Conatus Pharmaceuticals Inc   0.39 
Amarin Corp Plcuk  0.38 
Arvinas Inc   0.38 
Nektar Therapeutics  0.38 
Vertex Pharmaceuticals Inc  0.38 
Hepion Pharmaceuticals Inc   0.37 
Axsome Therapeutics Inc   0.37 
Cormedix Inc   0.37 
Neurobo Pharmaceuticals Inc   0.37 
Savara Inc   0.37 
Zogenix Inc   0.37 
Bridgebio Pharma Inc   0.36 
Agios Pharmaceuticals Inc   0.36 
Vascular Biogenics Ltd   0.36 
Evoke Pharma Inc  0.35 
Abeona Therapeutics Inc   0.35 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MCK's Profile

Stock Price

MCK's Financials

Business Description

Fundamentals

Charts & Quotes

MCK's News

Suppliers

MCK's Competitors

Customers & Markets

Economic Indicators

MCK's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071